About PathCision Medicine
PathCision Medicine is a company based in Watertown (United States) founded in 2022 by David Lee and Shana Wang. PathCision Medicine has raised $1.9 million across 2 funding rounds. PathCision Medicine operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Watertown, United States
- Founders David Lee, Shana Wang
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.9 M (USD)
in 2 rounds
-
Latest Funding Round
$200 K (USD), Seed
Feb 06, 2024
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of PathCision Medicine
PathCision Medicine has successfully raised a total of $1.9M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $200 thousand completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by PathCision Medicine
Investment portfolio details for PathCision Medicine
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PathCision Medicine
Detailed financials for PathCision Medicine
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pathcision Medicine Comparisons
Peer comparison for PathCision Medicine
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PathCision Medicine
PathCision Medicine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| Locked | Locked | Locked |
Small molecules are developed for cancer and skin disease treatments.
|
|
| Locked | Locked | Locked |
Cancer therapies are developed using selective pathway inhibitors.
|
Detailed competitors of PathCision Medicine
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pathcision Medicine
Complete news archive for PathCision Medicine
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PathCision Medicine
PathCision Medicine was founded in 2022.
PathCision Medicine is headquartered in Watertown, United States.
Shana Wang is the current CEO of PathCision Medicine. They have also founded this company.
PathCision Medicine is a funded company, having raised a total of $1.9M across 2 funding rounds to date.
PathCision Medicine was founded in 2022 and is based in Watertown, United States. Operations focus on the biotechnology sector, where targeted therapies for metastatic cancer are developed. Tissue pathology insights are utilized to create a biologic modality enabling metastasis-selective delivery for various indications. The approach addresses unmet needs in oncology through precise therapeutic mechanisms.
PathCision Medicine's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.